P47 How Do HTA Agencies Manage Uncertainties in the Long-Term Clinical Benefit of Gene Therapies? An Analysis of Recent Gene Therapy HTAs in England, Germany, France, Italy, Canada, and the United States
Abstract
Authors
B. McCormick C. Sheppard E. Hutt S. Schmitz A. Kumar